Total Funding
24
37
Total FundingPost-IPO Equity raised
Growth Score
-29 pts
Heat Score
-19 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
164472
Cassava Sciences is a clinical-stage biopharmaceutical company focused on neuroscience.
- Nadav Friedmann: Chief Medical Officer
Eric Schoen: Chief Financial Officer
About the Company
Cassava Sciences is a clinical-stage biopharmaceutical company focused on neuroscience. We translate novel scientific insights into new medicines. That’s a drastic challenge. Our work is complex, risky, labor-intensive, persistent and expensive.
